5 article(s) from Mező, Gábor
Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids
- Eszter Lajkó,
- Sarah Spring,
- Rózsa Hegedüs,
- Beáta Biri-Kovács,
- Sven Ingebrandt,
- Gábor Mező and
- László Kőhidai
Beilstein J. Org. Chem. 2018, 14, 2495–2509, doi:10.3762/bjoc.14.226
Drug targeting to decrease cardiotoxicity – determination of the cytotoxic effect of GnRH-based conjugates containing doxorubicin, daunorubicin and methotrexate on human cardiomyocytes and endothelial cells
- Livia Polgár,
- Eszter Lajkó,
- Pál Soós,
- Orsolya Láng,
- Marilena Manea,
- Béla Merkely,
- Gábor Mező and
- László Kőhidai
Beilstein J. Org. Chem. 2018, 14, 1583–1594, doi:10.3762/bjoc.14.136
On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
- Eirinaios I. Vrettos,
- Gábor Mező and
- Andreas G. Tzakos
Beilstein J. Org. Chem. 2018, 14, 930–954, doi:10.3762/bjoc.14.80
Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property
- Andrea Angelo Pierluigi Tripodi,
- Szilárd Tóth,
- Kata Nóra Enyedi,
- Gitta Schlosser,
- Gergely Szakács and
- Gábor Mező
Beilstein J. Org. Chem. 2018, 14, 911–918, doi:10.3762/bjoc.14.78
Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
- Sabine Schuster,
- Beáta Biri-Kovács,
- Bálint Szeder,
- Viktor Farkas,
- László Buday,
- Zsuzsanna Szabó,
- Gábor Halmos and
- Gábor Mező
Beilstein J. Org. Chem. 2018, 14, 756–771, doi:10.3762/bjoc.14.64
Other Beilstein-Institut Open Science Activities
